Pharming Group N.V.

DB:PHGN Stock Report

Market Cap: €498.9m

Pharming Group Future Growth

Future criteria checks 4/6

Pharming Group is forecast to grow earnings and revenue by 73.2% and 9.7% per annum respectively. EPS is expected to grow by 72.1% per annum. Return on equity is forecast to be 10.9% in 3 years.

Key information

73.2%

Earnings growth rate

72.1%

EPS growth rate

Biotechs earnings growth39.7%
Revenue growth rate9.7%
Future return on equity10.9%
Analyst coverage

Low

Last updated04 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:PHGN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263601919264
12/31/202532015114
12/31/2024289-10274
9/30/2024286-1800N/A
6/30/2024278-13-6-6N/A
3/31/2024258-1118-2N/A
12/31/2023245-113-17N/A
9/30/2023219-22-4-24N/A
6/30/2023206-165-15N/A
3/31/2023202-2-3-1N/A
12/31/2022206142022N/A
9/30/2022204302533N/A
6/30/2022202211526N/A
3/31/2022202111731N/A
12/31/2021199162138N/A
9/30/2021200222943N/A
6/30/2021200314052N/A
3/31/2021202375970N/A
12/31/2020212386884N/A
9/30/2020212447085N/A
6/30/2020202465993N/A
3/31/2020202425384N/A
1/1/2020189414974N/A
9/30/2019175384870N/A
6/30/2019175345963N/A
3/31/2019158295457N/A
12/31/2018155294246N/A
9/30/2018152-295763N/A
6/30/2018138-44N/A61N/A
3/31/2018128-80N/A52N/A
12/31/2017108-91N/A46N/A
9/30/201776-53N/A14N/A
6/30/201747-47N/A-6N/A
3/31/201731-21N/A-13N/A
12/31/201617-18N/A-11N/A
9/30/201612-16N/A-18N/A
6/30/201612-15N/A-18N/A
3/31/201613-14N/A-18N/A
12/31/201512-11N/A-19N/A
9/30/2015298N/A-3N/A
6/30/2015279N/A-1N/A
3/31/20152310N/A-3N/A
12/31/201426-7N/A-3N/A
9/30/20146-29N/A-19N/A
6/30/20146-35N/A-16N/A
3/31/201411-35N/A-14N/A
12/31/20139-21N/A-11N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PHGN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: PHGN is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: PHGN is expected to become profitable in the next 3 years.

Revenue vs Market: PHGN's revenue (9.7% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: PHGN's revenue (9.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: PHGN's Return on Equity is forecast to be low in 3 years time (10.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y